Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
Published January 22, 2020 · Recall initiated: December 17, 2019
Summary
FDA records drug Class I recall D-0655-2020, published January 22, 2020 and initiated December 17, 2019. Recalling firm: Motto International Corp; Status: Terminated; Reported quantity: 7 boxes; Lot: All lots remaining within expiry. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Motto International Corp
- Distributor
- TX
- Lot
- All lots remaining within expiry.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4January 22, 2020
- FDARhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologramJanuary 22, 2020
- FDAPanther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging,January 22, 2020
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDCJanuary 22, 2020
- FDAImplantDirect InterActive Precision IO Scan Adapter, Part #6530-09PT, Platform: 3.0mm, Non-Sterile, Rx. TheJanuary 15, 2020
- FDAImplantDirect InterActive Precision IO Scan Adapter, Part #6534-09PT, Platform: 3.4mm, Non-Sterile, Rx. TheJanuary 15, 2020
Questions about this recall
Was Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX recalled?
Yes. FDA published recall D-0655-2020 on January 22, 2020. Reported hazard: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What should I do if I have this product?
Voluntary: Firm initiated · Press Release